|
|
|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 17-26
|
|
The current status of docetaxel for metastatic breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
BREAST TUMOR;
DRUG RESISTANCE;
FEMALE;
HUMAN;
PHASE 3 CLINICAL TRIAL;
REVIEW;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0036615310
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (16)
|
|
References (56)
|
